World

Germany identifies its first case of new mpox variant

Oct 23, 2024

Berlin [Germany], October 23: Germany has detected its first case of the new mpox variant, the Robert Koch Institute for public health said, adding that it viewed the risk to the wider population as low.
The patient is a 33-year-old man who was isolated after being admitted to hospital for treatment on Oct. 12, the health ministry in the western state of North Rhine-Westphalia said.
The case was detected in Cologne, the ministry said in a statement.
The results of more detailed testing showed on Oct. 18 that the patient had the clade 1b variant, a new form of the virus that is linked to a global health emergency declared by the World Health Organization in August.
The current outbreak originated in the Democratic Republic of Congo and has spread to neighbouring countries.
The patient in Germany is thought to have picked up the virus in an east African country, the state ministry said.
"The RKI currently considers the risk to the health of the general population in Germany to be low," the RKI said, adding it was monitoring the situation closely and would adapt its assessment if necessary.
The RKI noted close physical contact was required for transmission.
The first sign of the virus' spread outside the African continent came on Aug. 15 when global health officials confirmed an infection with a new strain of the mpox virus in Sweden.
Two patients in Norway have been diagnosed with the clade 2 variety of the mpox virus, the Oslo municipality said on Tuesday. Clade 2 is a less severe form of mpox than the clade 1b strain.
Source: Fijian Broadcasting Corporation

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024